BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17045937)

  • 1. Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure.
    Grigioni F; Potena L; Galiè N; Fallani F; Bigliardi M; Coccolo F; Magnani G; Manes A; Barbieri A; Fucili A; Magelli C; Branzi A
    J Heart Lung Transplant; 2006 Oct; 25(10):1241-6. PubMed ID: 17045937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics.
    Grigioni F; Barbieri A; Russo A; Reggianini L; Bonatti S; Potena L; Fabbri F; Coccolo F; Magnani G; Bursi F; Magelli C; Modena MG; Branzi A
    J Heart Lung Transplant; 2006 Jun; 25(6):648-52. PubMed ID: 16730570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial versus isolated assessment of clinical and instrumental parameters in heart failure: prognostic and therapeutic implications.
    Grigioni F; Barbieri A; Magnani G; Potena L; Coccolo F; Boriani G; Specchia S; Carigi S; Musuraca A; Zannoli R; Magelli C; Branzi A
    Am Heart J; 2003 Aug; 146(2):298-303. PubMed ID: 12891199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation.
    Grigioni F; Russo A; Potena L; Ielasi A; Fabbri F; Bacchi-Reggiani L; Carigi S; Musuraca AC; Bigliardi M; Coccolo F; Magnani G; Specchia S; Magelli C; Branzi A
    J Heart Lung Transplant; 2006 Jan; 25(1):85-9. PubMed ID: 16399535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors.
    Güder G; Frantz S; Bauersachs J; Allolio B; Wanner C; Koller MT; Ertl G; Angermann CE; Störk S
    Circ Heart Fail; 2009 Nov; 2(6):563-71. PubMed ID: 19919981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of pulmonary artery pressure by echocardiography to predict outcome in patients receiving cardiac resynchronization therapy heart failure.
    Shalaby A; Voigt A; El-Saed A; Saba S
    Am J Cardiol; 2008 Jan; 101(2):238-41. PubMed ID: 18178413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between reactive pulmonary hypertension and mortality in patients with acute decompensated heart failure.
    Aronson D; Eitan A; Dragu R; Burger AJ
    Circ Heart Fail; 2011 Sep; 4(5):644-50. PubMed ID: 21606213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.
    Poelzl G; Eberl C; Achrainer H; Doerler J; Pachinger O; Frick M; Ulmer H
    Circ Heart Fail; 2009 Jul; 2(4):294-302. PubMed ID: 19808352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peak cardiac power output, measured noninvasively, is a powerful predictor of outcome in chronic heart failure.
    Lang CC; Karlin P; Haythe J; Lim TK; Mancini DM
    Circ Heart Fail; 2009 Jan; 2(1):33-8. PubMed ID: 19808313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure.
    Johansson M; Gao SA; Friberg P; Annerstedt M; Carlström J; Ivarsson T; Jensen G; Ljungman S; Mathillas O; Nielsen FD; Strömbom U
    J Hypertens; 2007 Jan; 25(1):163-8. PubMed ID: 17143188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive estimation of pulmonary arterial blood pressure in burned patients with acute respiratory failure.
    Szabó K; Jokkel G; Pick R
    Acta Physiol Hung; 1991; 78(1):27-41. PubMed ID: 1763649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.
    Andersen KH; Iversen M; Kjaergaard J; Mortensen J; Nielsen-Kudsk JE; Bendstrup E; Videbaek R; Carlsen J
    J Heart Lung Transplant; 2012 Apr; 31(4):373-80. PubMed ID: 22226804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study.
    Sanz J; García-Alvarez A; Fernández-Friera L; Nair A; Mirelis JG; Sawit ST; Pinney S; Fuster V
    Heart; 2012 Feb; 98(3):238-43. PubMed ID: 21917658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database.
    Khush KK; Tasissa G; Butler J; McGlothlin D; De Marco T;
    Am Heart J; 2009 Jun; 157(6):1026-34. PubMed ID: 19464413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
    Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation.
    Butler J; Stankewicz MA; Wu J; Chomsky DB; Howser RL; Khadim G; Davis SF; Pierson RN; Wilson JR
    J Heart Lung Transplant; 2005 Feb; 24(2):170-7. PubMed ID: 15701433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure.
    Ingle L; Goode K; Carroll S; Sloan R; Boyes C; Cleland JG; Clark AL
    Int J Cardiol; 2007 Jun; 118(3):350-5. PubMed ID: 17067694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.